We have been recognized as Best Managed Company for the fourth time in a row – and now carrying gold status. The internationally renowned award is presented annually by Deloitte Private, Frankfurter Allgemeine Newspaper and the Federation of German Industries (BDI) to medium-sized and family-run companies in over 40 countries.
"We are very proud to have been awarded this prestigious seal of quality for the fourth time," says our Managing Director Peter Soelkner. "As a leading service provider in the production of complex injectable drugs, we are an innovative and reliable partner for our large and small customers – especially in economically challenging times. We see this award as a further confirmation that we are on the right track."
Earning this recognition requires a comprehensive and sustainable strategy. This is Vetter NExT 2029: six initiatives with 26 fields of action and four focus topics worked on by interdisciplinary teams with progress tracked regularly. Our entire value chain is strategically covered. Higher-level topics of modern business operations are also addressed, such as digital transformation, organizational development, and sustainability.
Pioneer in sustainability
The judges also set high standards for the sustainability assessment. As one of the leading companies in the highly regulated and energy-intensive biopharma industry, we have already been CO2-neutral worldwide since 2021. Last year, we published our first comprehensive sustainability report and achieved gold status in the internationally recognized EcoVadis ranking. At the beginning of this year, we joined the UN Global Compact and are thus driving the expansion of responsible supply chains in the industry and sustainable business processes. The sustainability activities are an integral part of the corporate strategy and cover the areas of economy, ecology, and social issues.
Holistic innovation management for future technologies
An integral part of the corporate strategy is the innovation management process, through which trends are recognized at an early stage and converted into innovations in a targeted manner. The focus lays on sustainable technologies, processes, products, and services. One example is the optimization of production-related processes using new intelligent technologies.
"We continue to develop topic areas in line with customer demands, such as the interaction of man and machine in assistance systems or the use of cooperative and autonomous robots. These initiatives are compelling and at the same time essential in order to offer our customers innovative solutions, and consequently being able to partner at eye level," explains our Managing Director Thomas Otto. The goal is to continuously improve flexibility, productivity, quality, IT, and operational safety.
Markus Seiz, Program Manager Best Managed Company and Director at Deloitte Private, explains the judge’s assessment as follows: "In all social crises, we look at the resilience and stability of the participating candidates. As a family-owned company, Vetter offers these success factors to a high degree, among others through its forward-looking and holistic strategic planning. In addition, the pharmaceutical service provider is already a leader in key transformation topics such as sustainability. These fields of action ensure future viability, resulting in Vetter being 'Best in Class' for us again this year."